{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:26:37Z","timestamp":1778768797569,"version":"3.51.4"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,4,24]],"date-time":"2006-04-24T00:00:00Z","timestamp":1145836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Mater Res"],"published-print":{"date-parts":[[2006,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A novel heparin\u2010 and cellulose\u2010based biocomposite is fabricated by exploiting the enhanced dissolution of polysaccharides in room temperature ionic liquids (RTILs). This represents the first reported example of using a new class of solvents, RTILs, to fabricate blood\u2010compatible biomaterials. Using this approach, it is possible to fabricate the biomaterials in any form, such as films or membranes, fibers (nanometer\u2010 or micron\u2010sized), spheres (nanometer\u2010 or micron\u2010sized), or any shape using templates. In this work, we have evaluated a membrane film of this composite. Surface morphological studies on this biocomposite film showed the uniformly distributed presence of heparin throughout the cellulose matrix. Activated partial thromboplastin time and thromboelastography demonstrate that this composite is superior to other existing heparinized biomaterials in preventing clot formation in human blood plasma and in human whole blood. Membranes made of these composites allow the passage of urea while retaining albumin, representing a promising blood\u2010compatible biomaterial for renal dialysis, with a possibility of eliminating the systemic administration of heparin to the patients undergoing renal dialysis. \u00a9 2006 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006<\/jats:p>","DOI":"10.1002\/jbm.b.30542","type":"journal-article","created":{"date-parts":[[2006,4,24]],"date-time":"2006-04-24T18:25:01Z","timestamp":1145903101000},"page":"298-304","source":"Crossref","is-referenced-by-count":35,"title":["Ionic liquid\u2010derived blood\u2010compatible composite membranes for kidney dialysis"],"prefix":"10.1002","volume":"79B","author":[{"given":"Saravanababu","family":"Murugesan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaker","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aravind","family":"Vijayaraghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pulickel M.","family":"Ajayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Linhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02388"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139X.2001.00078.x"},{"key":"e_1_2_5_5_2","first-page":"491","article-title":"A review of heparin use in hemodialysis and peritoneal dialysis","volume":"22","author":"Brieterman\u2010White R","year":"1995","journal-title":"ANNA J"},{"key":"e_1_2_5_6_2","first-page":"1607","article-title":"Low molecular weight heparin in preventing and treating DVT","volume":"59","author":"Rydberg EJ","year":"1999","journal-title":"Am Fam Physician"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139X.2003.03014.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7089564"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.2.252"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(97)00310-1"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000116026.18945.66"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0142-9612(96)81422-0"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1021347810130"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4636(20010305)54:3<436::AID-JBM180>3.0.CO;2-8"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.820230110"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1039\/b107270f"},{"key":"e_1_2_5_17_2","first-page":"33","article-title":"Ionic liquids: Designer solvents for green synthesis","volume":"730","author":"Seddon KR","year":"2002","journal-title":"Tce"},{"key":"e_1_2_5_18_2","first-page":"1283","article-title":"Dialkyl imidazolium benzoates\u2014Room temperature ionic liquids useful in peracetylation and perbenzoylation of simple and sulfated saccharides","volume":"9","author":"Murugesan S","year":"2003","journal-title":"Synlett"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.2174\/157017905774322640"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja025790m"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2005.09.022"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(62)90095-7"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(01)00248-6"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(96)01611-2"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4628(19991017)74:3<655::AID-APP19>3.0.CO;2-N"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2003.08.027"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(97)00015-X"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-3057(01)00015-5"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200212000-00008"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijoa.2003.10.009"},{"key":"e_1_2_5_31_2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2174\/1381612805666230112205420","article-title":"Development of heparin antagonists with focused biological activity","volume":"5","author":"Shenoy S","year":"1999","journal-title":"Curr Pharm Des"}],"container-title":["Journal of Biomedical Materials Research Part B: Applied Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbm.b.30542","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbm.b.30542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T23:10:09Z","timestamp":1697152209000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jbm.b.30542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,24]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["10.1002\/jbm.b.30542"],"URL":"https:\/\/doi.org\/10.1002\/jbm.b.30542","archive":["Portico"],"relation":{},"ISSN":["1552-4973","1552-4981"],"issn-type":[{"value":"1552-4973","type":"print"},{"value":"1552-4981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,24]]}}}